Article Information
History
- April 18, 2024.
Article Versions
- Version 1 (April 12, 2024 - 19:45).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Steven Tobochnik1,2,*,
- Michael S. Regan3,
- Maria K. C. Dorotan1,
- Dustine Reich8,
- Emily Lapinskas1,
- Md Amin Hossain3,
- Sylwia Stopka3,
- Sandro Santagata4,5,
- Melissa M. Murphy1,
- Omar Arnaout3,
- Wenya Linda Bi3,
- E. Antonio Chiocca3,
- Alexandra J. Golby3,7,
- Michael A. Mooney3,
- Timothy R. Smith3,
- Keith L. Ligon4,5,
- Patrick Y. Wen6,
- Nathalie Y. R. Agar3,7 and
- Jong Woo Lee1
- 1Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
- 2Department of Neurology, VA Boston Healthcare System, Boston, MA, USA
- 3Department of Neurosurgery, Brigham and Women’s Hospital, Boston, MA, USA
- 4Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
- 5Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA
- 6Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 7Department of Radiology, Brigham and Women’s Hospital, Boston, MA, USA
- 8Weill Cornell Medical College, New York, NY, USA
- ↵*Corresponding author: Steven Tobochnik, MD Department of Neurology 60 Fenwood Rd, BTM 4th Floor Boston, MA 02115 Phone: 617-732-7432 stobochnik{at}bwh.harvard.edu
Posted April 18, 2024.
Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma
